The present study seeks to establish a relationship between the quality of a surgical procedure and the subsequent hospital costs for that procedure by investigating the influence of both patient and peri-operative factors on the hospital costs of radical prostatectomy. All men who underwent radical prostatectomy at one institution during an 18-month period were included in this study. Clinical information was obtained from medical records and cost information was obtained from hospital billing data. The medical record was also used to determine peri-operative information such as operating room time, anesthesia time, surgical time, blood loss and units of packed red blood cells transfused. The correlation between costs and both clinical and peri-operative factors were determined using the Pearson correlation co-efficient. One hundred and four men underwent radical prostatectomy at our institution during the time period studied. Mean age of these patients was 60.2 y and mean length of stay for these patients was 3.4 days with a range of 2 -10 days. Mean total hospital costs for this cohort was $5305 with a range of $2851 -$10 358. Significant correlations with total hospital costs included operating room time, surgical time, estimated blood loss and blood transfused. Patient factors such as age, ASA class, co-morbidities and smoking history were not correlated with total hospital costs. The present study demonstrates that factors at least partially controlled by the surgeon such as surgical time and units of blood transfused directly influence the total hospital costs of radical prostatectomy, while patient factors such as age and the presence of co-morbidities had no significant correlation with total hospital costs. These findings demonstrate that surgeons can impact health care costs by providing high quality care and begins to establish a relationship between high quality care and low cost care. Prostate Cancer and Prostatic Diseases (2001) 4, 213-216.
Introduction
Managed care has been increasingly utilized to decrease health care costs. Unfortunately, managed care as currently practiced is not true managed care in the sense of efficient disease management but rather focuses on managing costs. The payers of health care are managing costs by transferring risk to health care providers, by extracting deeper and deeper discounts from hospitals and medical specialists, and by focusing on attracting healthy patients to their plans. These managed costs techniques have resulted in what has been termed a 'disordered disorder' in health care since the three major participants in health care (the patients, the payers, and the providers) are unable to adequately achieve their goals from the health care marketplace. 1 Patients desire full access to quality providers and services; payers aim to deliver care that is as low cost as possible while still obtaining an acceptable level of satisfaction among their members; and providers seek access to patients, the freedom to deliver the quality care their patients desire and to be reimbursed at an appropriate level for their efforts. The current managed care environment in many instances has led to decreased provider access for patients, decreased patient satisfaction, and decreased provider reimbursement which have not all necessarily decreased health care costs.
One reason that only a few plans are able to manage clinical care quality through improved disease management is the lack of objective data on quality and costs. In an efficient marketplace, patients would be drawn to high quality providers and services while payers would be drawn to low cost care, and an equilibrium between these two forces would be realized. Due to the lack of quality and cost data, the health care marketplace remains highly inefficient because it is not directed by appropriate market disciplines. The present study attempts to evaluate the relationship between costs and quality by reporting which factors affect the hospital costs of radical prostatectomy.
Radical prostatectomy remains the standard of care for the treatment of clinically localized prostate cancer in the appropriate patient. As such, radical prostatectomy is one of the most common procedures performed by urologists. 2 The costs of this procedure as well as which factors affect those costs are critically important to urologists, their patients, and the payers of health care. By determining which factors control the hospital costs of radical prostatectomy, the present study attempts to demonstrate a relationship between quality and costs.
Methods
All men who underwent radical prostatectomy at our institution during an 18-month period beginning in January 1995 were included in this study. Hospital bills were generated for each patient. Hospital costs were divided into 11 categories, including operating room time, operating room equipment, ward, laboratory, pharmacy, anesthesia, short procedure unit (same day surgery admitting unit), recovery room, radiology, other costs, and total costs. Laboratory costs included those for chemistry, hematology, blood bank and pathology. Other costs included those for respiratory care, cardiology studies and miscellaneous costs. The hospital bills were also used to determine non-cost information such as patient age, length of stay, and operating room units charged to the patient.
Allegheny General Hospital uses a cost accounting system that identifies direct, indirect, fixed and variable costs associated with all procedures. Cost information for each patient was supplied by the finance department at Allegheny General Hospital. It is important to note that this study focuses on actual costs rather than charges. The only costs not included in this study were those of the physician. Physician costs for this procedure would include those of the surgeon, assistant surgeon, anesthesiologist and any physician that may have seen the patient in consultation during the post-operative period. The rationale for not including physician costs is two-fold. First, physician costs do not equal physician reimbursement. Physician reimbursement will vary depending on the patient's insurance carrier and is therefore very difficult to quantify. Additionally, as capitation continues to penetrate the health care marketplace physician fees will have decreasing importance.
Medical records were reviewed to obtain clinical information. Pre-treatment Gleason score, serum prostate specific antigen (PSA), and clinical stage were recorded for each patient. Clinical stages were segregated into T1 and T2 lesions. The medical record was also used to obtain operating room time, anesthesia time, surgical time, blood loss, units of packed red blood cells transfused, availability of autologous blood, and type of pain control used in the post-operative period. Blood loss was estimated by anesthesia and was obtained by reviewing the anesthesia record. Operating room time was defined as the time the patient entered the operating room to the time the patient left the operating room. Surgical time was defined as the time from the start of the incision to the time the incision was closed. Anesthesia time was calculated by subtracting surgical time from operating room time. Estimates of patient co-morbidity such as ASA class, smoking history and the presence of diabetes mellitus were also obtained from the medical record. Smoking history was considered positive if the patient had been a smoker within 3 months of the time of surgery. Correlations were analyzed using the Pearson correlation co-efficient.
Results
One hundred and four men underwent radical prostatectomy at Allegheny General Hospital during the time period studied. Mean age of these patients was 60.2 y with a range of 41 -72 y. Mean and median pre-treatment PSA was 8.5 ng/ml and 7.0 ng/ml, respectively, with a range of 0.3 -51.5 ng/ml and mean Gleason sum was 5.9 (range 3 -9). Clinical data for this cohort appears in Table  1 . Mean length of stay for these patients was 3.4 days with a range of 2 -10 days. Estimated blood loss averaged 1281 cc with a range of 175 -3400 cc. Forty-three patients (41.3%) received blood. All but six of these patients had donated autologous blood prior to the procedure. Therefore, only six patients (5.8%) received non-autologous blood. Mean total hospital costs for this cohort was $5305 with a range of $2851 -$10 358. Ward costs averaged $2156 and were the largest portion of hospital costs followed by operating room costs ($1366). Anesthesia costs averaged $654 while total laboratory costs per patient averaged $480. Costs for all categories studied appear in Table 1 .
Correlations between total hospital costs and the factors studied appear in Table 2 along with the appropriate P-value. Significant correlations with total hospital costs included operating room time, surgical time, estimated blood loss and units of blood transfused. Patient factors such as age, ASA class, presence of diabetes and smoking history were not correlated with total hospital costs. Tables 3 and 4 demonstrate the increasing hospital costs for increasing surgical time and units of packed red blood cells transfused, respectively. Table 5 demonstrates the mean total hospital costs for men aged 50 -54, 55 -59, 60 -64 and 65 -69. No significant difference existed when comparing the costs of these different age groups.
Discussion
The attempt to control health care costs has drastically changed the health care marketplace. Since surgical subspecialists rely heavily on procedures to generate income, they are especially vulnerable when managed care penetrates the health care marketplace. The concept of gatekeepers and the financial punishment of primary care providers for referring patients for specialty care have resulted in decreased access to patients for many urologists. In order for urologists to regain or simply maintain access to patients and restore their autonomy over clinical decisions, they must demonstrate the value of their services both to patients and payers. Patients seek access to providers they perceive as providing high quality care, while payers are primarily interested in securing care for their members which is as low cost as possible. To remain viable in the current marketplace, urologists must compete in the arenas of both cost and quality. The goal of this study is to begin to explore the relationship between costs and quality in the field of urologic surgery by evaluating how patient and operative factors affect the hospital costs of radical prostatectomy.
Quality in health care is both subjective and objective, and hence difficult to measure. Patients' perception of quality is largely subjective, and is related to interpersonal factors such as trust, listening skills, and a feeling of satisfaction from their visit. Waiting room time and office operation are important to patients, but less so than access to physicians of their choice. The quality of physicians in a plan is by far the most important consideration in choosing a health plan, followed closely by the ability to choose one's own doctors. 3 However, exactly how patients measure quality and which information patients use to make these decisions remains uncertain. 4 Payers tend to measure quality more objectively by focusing on patient admission rates and length of stay, while measuring patient satisfaction by way of survey.
The present study demonstrates that factors controlled (at least to some degree) by the surgeon have a statistically significant effect on the resulting hospital costs. Such factors at least partially controlled by the surgeon include surgical time, blood loss and units of red blood cells transfused. Blood loss can vary widely with radical prostatectomy and depends on many factors. Anatomical radical prostatectomy with early control of the dorsal venous complex has led to decreased blood loss resulting from the procedure. 5 Although even patients who are being treated by the most experienced surgeons can have substantial blood loss, it is likely that more experienced surgeons will have lower blood loss on average than surgeons who have less experience with the procedure. 6, 7 The number of packed red blood cells transfused has a higher correlation with total hospital costs (r ¼ 0.399, P < 0.001) than estimated blood loss (r ¼ 0.285, P < 0.01). This is likely due to the fact that units of blood transfused is a more sensitive indicator of the effect of blood loss on the patient than estimated blood loss. Table 4 demonstrates that hospital costs rise with each unit of blood transfused. The increase in costs associated with each unit transfused is not simply due to the cost of transfusing each unit as blood bank costs increased an average of $112 per additional unit of blood transfused while the mean increase in total hospital costs for each unit transfused is $555. Surgical time is also controlled to a large degree by the operating surgeon. Certainly all surgeons operate at their own unique pace, but most surgeons will decrease the time they take to complete a surgical procedure as they gain more experience with that particular procedure. Decreased surgical time for radical prostatectomy is therefore likely another indicator of the experience of the surgeon. Indeed, Kramalowsky and colleagues reported decreased surgical time as experience with radical prostatectomy increased. 8 Surgical time (defined as time from skin incision to skin closure) had a correlation coefficient of r ¼ 0.465 with total hospital costs. This correlation is not simply due to higher operating room costs due to longer surgical time, as operating room costs were not significantly correlated with total hospital costs. The relationship between outcomes and surgeon experience has been poorly studied. Most of the reports on this subject are from fields other than urologic surgery, where it has been demonstrated that increased surgical volumes are related to decreased peri-operative mortality. 9 -12 Patient factors not under the control of the surgeon (except when selecting patients) were not significantly correlated with hospital costs. These factors include patient age, smoking history, presence of diabetes and ASA class. None of these factors achieved significance in the present study. Hematology, chemistry and radiology costs did achieve significance. It is unlikely these factors had any real effect on total costs but rather are the result of patients with a longer length of stay having higher ancillary costs.
The quality of any surgical procedure is difficult to measure. Without question, the true measure of the quality of a radical prostatectomy will be long-term cancer control and a low incidence of morbidity (ie incontinence and impotence). The present study does not address these factors, focusing instead on the events surrounding the surgical procedure rather than long-term outcomes. Time honored surgical principles of decreased blood loss and decreased length of anesthesia are used as a proxy for the quality of the surgical technique in the present study. Using these parameters to measure the quality of a surgical procedure, the findings support the theory that high quality care is also low cost care.
Regardless of whether blood loss and time of operation are measures of the quality of a surgical procedure, the present study does demonstrate that factors at least partially controlled by the surgeon have a greater effect on the hospital costs of radical prostatectomy than factors that are not controlled by the surgeon such as patient age, ASA class and co-morbidities. This study suggests the effect that surgical skill and experience may have on total hospital costs. Urologists must continue to find methods to demonstrate the quality of the care they provide as well as their effect on total health care costs. By quantifying the quality of care they provide, urologists will make their practice more attractive to patients and, to a lesser degree, payers. By demonstrating the care that they provide is low cost, urologists will make their practice more attractive to payers. More importantly, by quantifying how the care they provide affects overall health care costs, urologists can demonstrate the value that well trained and skilled sub-specialists provide in the current health care marketplace.
Conclusions
The present study demonstrates that factors at least partially controlled by the surgeon such as surgical time and units of blood transfused directly influence the total hospital costs associated with radical prostatectomy. Patient factors such as age and the presence of co-morbidities had no significant correlation with hospital costs. These findings support the theory that quality care is also low cost care. Physicians who can provide and document their delivery of high quality and low cost care will begin to reassert their strength in the health care marketplace. Patients will demand access to those providers and payers will be willing to allow that access given the low cost care that is being delivered. This study also suggests that urologists should make their claim to increased market share by demonstrating their effect on total health care costs rather than competing strictly on the basis of professional fees. Physicians who become accountable for cost as well as outcomes will take the first step in the journey to restore their professional autonomy, regain freedom from interference, and benefit economically from their contribution to their patients' health.
